U.S. flag

An official website of the United States government

NM_004006.3(DMD):c.8038C>T (p.Arg2680Ter) AND Duchenne muscular dystrophy

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Aug 10, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000201174.13

Allele description [Variation Report for NM_004006.3(DMD):c.8038C>T (p.Arg2680Ter)]

NM_004006.3(DMD):c.8038C>T (p.Arg2680Ter)

Gene:
DMD:dystrophin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xp21.1
Genomic location:
Preferred name:
NM_004006.3(DMD):c.8038C>T (p.Arg2680Ter)
HGVS:
  • NC_000023.11:g.31627852G>A
  • NG_012232.1:g.1716758C>T
  • NM_000109.4:c.8014C>T
  • NM_004006.3:c.8038C>TMANE SELECT
  • NM_004009.3:c.8026C>T
  • NM_004010.3:c.7669C>T
  • NM_004011.4:c.4015C>T
  • NM_004012.4:c.4006C>T
  • NM_004013.3:c.658C>T
  • NM_004020.4:c.658C>T
  • NM_004021.3:c.658C>T
  • NM_004022.3:c.658C>T
  • NM_004023.3:c.658C>T
  • NP_000100.3:p.Arg2672Ter
  • NP_003997.1:p.Arg2680Ter
  • NP_003997.2:p.Arg2680Ter
  • NP_004000.1:p.Arg2676Ter
  • NP_004001.1:p.Arg2557Ter
  • NP_004002.3:p.Arg1339Ter
  • NP_004003.2:p.Arg1336Ter
  • NP_004004.2:p.Arg220Ter
  • NP_004011.3:p.Arg220Ter
  • NP_004012.2:p.Arg220Ter
  • NP_004013.2:p.Arg220Ter
  • NP_004014.2:p.Arg220Ter
  • LRG_199t1:c.8038C>T
  • LRG_199:g.1716758C>T
  • LRG_199p1:p.Arg2680Ter
  • NC_000023.10:g.31645969G>A
  • NM_004006.2:c.8038C>T
Protein change:
R1336*
Links:
dbSNP: rs863225011
NCBI 1000 Genomes Browser:
rs863225011
Molecular consequence:
  • NM_000109.4:c.8014C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_004006.3:c.8038C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_004009.3:c.8026C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_004010.3:c.7669C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_004011.4:c.4015C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_004012.4:c.4006C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_004013.3:c.658C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_004020.4:c.658C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_004021.3:c.658C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_004022.3:c.658C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_004023.3:c.658C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Duchenne muscular dystrophy (DMD)
Synonyms:
Muscular dystrophy, pseudohypertrophic progressive, Duchenne type
Identifiers:
MONDO: MONDO:0010679; MedGen: C0013264; Orphanet: 98896; OMIM: 310200

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000550331Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Aug 10, 2022)
germlineclinical testing

PubMed (11)
[See all records that cite these PMIDs]

SCV004048201Neuberg Centre For Genomic Medicine, NCGM
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenicgermlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

The role of muscle biopsy in analysis of the dystrophin gene in Duchenne muscular dystrophy: experience of a national referral centre.

Tuffery-Giraud S, Saquet C, Chambert S, Echenne B, Marie Cuisset J, Rivier F, Cossée M, Philippe C, Monnier N, Bieth E, Recan D, Antoinette Voelckel M, Perelman S, Lambert JC, Malcolm S, Claustres M.

Neuromuscul Disord. 2004 Oct;14(10):650-8.

PubMed [citation]
PMID:
15351422

Protein- and mRNA-based phenotype-genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene.

Deburgrave N, Daoud F, Llense S, Barbot JC, Récan D, Peccate C, Burghes AH, Béroud C, Garcia L, Kaplan JC, Chelly J, Leturcq F.

Hum Mutat. 2007 Feb;28(2):183-95.

PubMed [citation]
PMID:
17041906
See all PubMed Citations (12)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000550331.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (11)

Description

For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 217213). This premature translational stop signal has been observed in individuals with Duchenne muscular dystrophy (DMD) (PMID: 15351422, 16770791, 17041906, 18583217, 19835634, 19937601, 21396098, 25612904, 25636106). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg2680*) in the DMD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DMD are known to be pathogenic (PMID: 16770791, 25007885).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Neuberg Centre For Genomic Medicine, NCGM, SCV004048201.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This sequence change creates a premature translational stop signal at codon 2680 (p.Arg2680*) of the DMD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DMD are known to be pathogenic (Aartsma‐Rus et al). This variant has been reported in individuals affected with Duchenne muscular dystrophy (DMD) (Magri, Francesca, et al,Tuffery-Giraud, Sylvie, et al). This variant has been reported to the ClinVar database as Pathogenic. The nucleotide change in DMD is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The variant is novel (not in any individuals) in gnomAD Exomes and 1000 Genomes. For these reasons, this variant has been classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024